Thermage vs Ultherapy Seoul | Evidence-Based Comparison

Both are non-surgical, FDA-cleared, single-session treatments with 1–2 year duration. Both are marketed in Seoul as "lifting." But they use fundamentally different energy types and target different tissue layers — and the patients who understand that difference make much better treatment decisions than the patients who just see "the popular lifting device."

The short version:

• Thermage = monopolar radiofrequency (RF). Bulk-heats the dermis and subdermis. Primary effect is tightening and thickening the skin envelope.
• Ultherapy = micro-focused ultrasound with visualization (MFU-V). Delivers discrete thermal coagulation points at three depths including the SMAS. Primary effect is structural lifting.

A treatment that works "at the SMAS" is not automatically better than one that works in the dermis — it depends on what is actually changing in your face. A patient whose main complaint is thin, crepey skin does not need SMAS work. A patient with jowl descent and jawline loss will not get structural correction from surface-only tightening.

This guide walks through the clinical evidence for each, what the comparison table actually supports, and how a dermatologist decides which one — or both — fits a given face.

Thermage is the brand name for Solta Medical's monopolar radiofrequency platform. It has been FDA-cleared since 2002 for non-invasive skin tightening, making it one of the longest-running energy-based aesthetic devices in the world. The current 4th-generation device is Thermage FLX, cleared under FDA 510(k) K170758 in 2017.

How monopolar RF works:

Unlike a laser (which delivers light absorbed by a specific chromophore), monopolar RF uses an electrical current that flows between a treatment tip and a return pad placed on the patient's back. The resistance of the dermis to this current generates bulk heat — roughly 65–75°C in the mid-dermis and subdermis. The skin surface is protected by a cryogen spray that fires immediately before and after each pulse.

Two things happen in tissue:

1. Immediate collagen contraction — existing Type I collagen fibers shorten under heat, producing a small but detectable tightening effect on treatment day.
2. Delayed neocollagenesis — the controlled thermal injury triggers fibroblast activity and new collagen synthesis over the following 2–6 months, which accounts for the bulk of the long-term result.

Four generations of Thermage:

• Thermage TC (2002) — first FDA clearance, single-pass high-fluence protocol, notably painful.
• Thermage NXT (2009) — multi-pass lower-fluence protocol, substantially improved pain profile.
• Thermage CPT (2009) — Comfort Pulse Technology, added vibration to modulate pain perception, expanded tip sizes.
• Thermage FLX (2017) — AccuREP auto-calibration per pulse (the device measures tissue impedance and adjusts delivered energy in real time), 4× the vibration of CPT, larger 4.0 cm² tip that cuts full-face treatment to 45–60 minutes, and a dedicated eye tip for Eye Thermage.

Patients treated with earlier-generation devices often remember significant pain. Modern Thermage FLX is substantially more comfortable but is not painless — it remains a heat-based treatment and typically ranks around 4–6 on a 10-point pain scale in most published series.

Clinical evidence:

The multicenter pivotal trial (Fitzpatrick R, Geronemus R, Goldberg D, et al. Lasers in Surgery and Medicine. 2003;33(4):232-242) established that a single monopolar RF treatment produced measurable periorbital tightening with acceptable safety in 86 subjects. This was the data that supported the initial FDA clearance.

Subsequent clinical experience established the shift from a single-pass high-fluence protocol to multi-pass lower-fluence delivery, which substantially improved comfort and reproducibility compared to the original approach.

A 2015 review of noninvasive skin tightening techniques (Fabi SG. Clinical, Cosmetic and Investigational Dermatology. 2015;8:47-52) concluded that the evidence supports consistent moderate improvement for monopolar RF with an excellent safety profile when protocols are followed correctly.

Honest caveats:

• Thermage is a moderate-improvement treatment in the published literature — not a facelift substitute.
• Results are gradual. Patients expecting dramatic next-day change will be disappointed.
• Results are highly technique-dependent — tip placement, pulse count, and energy level all affect outcome.
• Rare but documented complications include subcutaneous fat atrophy with incorrect settings, transient neuropathic pain, and surface burns when the return pad is improperly placed.

Korean-specific note: Solta Medical operates a TTT (Thermage Therapy Trainer) Master certification program in Korea. Clinics with TTT Master-certified dermatologists have completed advanced protocol training from the manufacturer. This certification is worth asking about directly when comparing Seoul clinics.

Ultherapy is the brand name for Merz Aesthetics' micro-focused ultrasound device (current platform: Ultherapy Prime). It is the only FDA-cleared device that uses real-time ultrasound imaging to guide non-invasive skin lifting.

Regulatory history:

• 2009 — First FDA clearance for non-invasive eyebrow lift (the first device of any kind cleared for this indication).
• 2012 — Clearance extended to neck and submental (under-chin) skin.
• 2014 — Clearance for lines and wrinkles on the décolletage.
• 2025 — Ultherapy Prime cleared for arms and abdomen.

How MFU-V works:

Focused ultrasound creates discrete thermal coagulation points (TCPs) — tiny volumes of tissue briefly heated to 60–70°C at a precise predetermined depth. Unlike RF, which heats tissue in bulk, MFU-V creates arrays of small coagulation points with untreated tissue in between. This pattern appears to drive a different kind of wound-healing response.

The distinctive feature is DeepSEE visualization — integrated real-time ultrasound imaging to 8 mm depth, allowing the practitioner to see tissue layers, blood vessels, and (near the mandibular border) nerves before firing. No other focused ultrasound device has integrated imaging.

Ultherapy delivers energy at three standard depths:

• 1.5 mm — superficial dermis (skin quality, texture).
• 3.0 mm — deep dermis (collagen remodeling).
• 4.5 mm — SMAS (superficial musculoaponeurotic system, the fibromuscular layer surgeons address in a facelift).

Reaching the SMAS non-invasively is Ultherapy's signature claim and is the reason the device is positioned specifically as "lifting" rather than "tightening."

Clinical evidence:

• Alam et al. (2010, J Am Acad Dermatol, PMID: 20115948) — Rater-blinded prospective cohort: 86% of subjects showed clinically significant brow lift at 90 days.
• Werschler & Werschler (2016, J Clin Aesthet Dermatol, PMC4771387) — Long-term follow-up: 95% of patients still showed improvement at 1 year.
• Amiri et al. (2025, Aesthetic Surgery Journal, PMID: 39540440) — Meta-analysis of 42 studies: 89% investigator-assessed improvement, 84% patient satisfaction, favorable safety profile across 50+ trials.

The anonymous-survey caveat:

Chang et al. (2019, Lasers in Surgery and Medicine, PMID: 30664263) surveyed 459 Ultherapy patients anonymously and found overall satisfaction was 53.1% — meaningfully lower than the 80–95% reported in non-anonymous industry-sponsored trials. Many Ultherapy efficacy studies are co-authored by investigators with financial ties to Merz Aesthetics, and patients in open-label trials may feel pressure to report better outcomes than they actually experienced.

This does not mean Ultherapy does not work — the objective rater-blinded imaging data (Alam 2010) is real. But it does mean that patients deserve honest pre-treatment counseling about realistic results rather than marketing-driven expectations.

The most important disclosure in this entire guide:

There are no published head-to-head randomized trials comparing Thermage with Ultherapy. Every comparison in the literature — including this one — is indirect. Separate studies of separate cohorts with different protocols, different outcome measures, and different follow-up windows. Anyone who tells you "Thermage is better" or "Ultherapy is better" on the basis of published evidence is overstating what the data actually support.

What we can compare from available data:

A note on pricing: Seoul prices are typically 30–50% of US prices for both devices. The wide range within Seoul reflects three factors: (1) tip or transducer count, (2) certification status (TTT Master for Thermage, Gold Standard for Ultherapy), and (3) whether the session includes additional areas like neck and décolletage. We discuss red flags around unusually low prices in the Seoul context section of our related HIFU vs Ultherapy evidence guide.

The honest answer to "Thermage or Ultherapy?" is that they address different problems. A good consultation looks at your face and your goals first, then recommends based on what is actually changing — not based on which device the clinic happens to own.

Thermage tends to fit when the main concern is:

• Thin, crepey skin in need of dermal thickening (upper eyelids, décolletage, dorsum of hands)
• Texture and contour smoothing across the cheeks and jawline
• Subtle envelope tightening without dramatic contour change
• Full-face coverage in a single session
• Younger patients (30s–40s) in a preventative or maintenance mindset

Ultherapy tends to fit when the main concern is:

• Jowl descent, jawline loss, or early submental laxity — the SMAS matters here
• Brow descent producing a heavy upper eyelid
• Neck banding or sub-mandibular laxity
• Patients who want a "lift" rather than a "tighten"
• Patients over 40 with visible structural descent rather than just surface laxity

Combination protocols:

Because the two devices target different tissue layers with different mechanisms, they are not competitors — they are complementary. A common Seoul protocol for patients in their late 40s or 50s:

1. Ultherapy first for structural SMAS-level lifting (brow, jawline, neck)
2. Thermage 2–4 weeks later to thicken and tighten the dermal envelope on top

Many clinics offer combination packages at a discount over separate sessions. This is one of the few times the discount is medically rational rather than purely marketing-driven — the two treatments genuinely reinforce each other.

When neither is the right answer:

• If the main concern is volume loss (hollow temples, flat cheeks, loss of midface projection), the right answer is a collagen stimulator (Sculptra) or HA filler — not an energy device.
• If the main concern is sun damage pigmentation, the right answer is a pigment-specific laser (PicoPlus or QS Nd:YAG) — not RF or ultrasound.
• If the laxity is severe (visible jowls hanging below the jawline, deep platysmal bands), neither Thermage nor Ultherapy will deliver what a surgical lift would. Honest consultation should acknowledge this.

At Gangnam Delight Dermatology, we carry both Thermage FLX and Ultherapy Prime, and the consultation decides which one (or both) fits — not device loyalty.

1. Fitzpatrick R, Geronemus R, Goldberg D, et al. Multicenter study of noninvasive radiofrequency for periorbital tissue tightening. Lasers Surg Med. 2003;33(4):232-242.
2. Fabi SG. Noninvasive skin tightening: focus on new ultrasound techniques. Clin Cosmet Investig Dermatol. 2015;8:47-52.
3. FDA 510(k) Premarket Notification Database. Thermage FLX System — K170758 (Solta Medical, 2017). FDA 510(k) Database
4. Alam M, White LE, Martin N, et al. Ultrasound tightening of facial and neck skin: a rater-blinded prospective cohort study. J Am Acad Dermatol. 2010;62(2):262-269. PubMed
5. Werschler WP, Werschler PS. Long-term efficacy of micro-focused ultrasound with visualization for lifting and tightening lax facial and neck skin. J Clin Aesthet Dermatol. 2016;9(2):27-33. PMC
6. Chang YC, Liu HL, Huang YC, et al. Objective and patient-reported outcomes after 459 microfocused ultrasound treatments. Lasers Surg Med. 2019;51(6):495-499. PubMed
7. Amiri M, et al. Micro-focused ultrasound with visualization for facial skin tightening: a systematic review and meta-analysis. Aesthet Surg J. 2025;45(3):NP86-NP94. PubMed
8. Friedmann DP, et al. A series of patients with complications from microfocused ultrasound. Lasers Surg Med. 2018;50(1):13-19. PubMed